Old Web
English
Sign In
Acemap
>
Paper
>
P1-039 セルトリズマブペゴルの従来型TNF阻害薬と異なるプロファイルDifferent Profiles of Certolizumab Pegol from other TNF inhibitors
P1-039 セルトリズマブペゴルの従来型TNF阻害薬と異なるプロファイルDifferent Profiles of Certolizumab Pegol from other TNF inhibitors
2012
Tadao Okamoto
Yumiko Wada
Tim Bourne
Gianluca Fossati
Alistair J. Henry
Roger Palframan
Sue Stephens
Alexander Vugler
Roly Foulkes
Neil Gozzard
Jeffrey D. Kennedy
Andrew Nesbitt
Keywords:
Immunology
Tumor necrosis factor alpha
Certolizumab pegol
Medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]